Skip to main content

Table 1 Demographic and baseline characteristics

From: Clinical impact of LH rises prior to and during ganirelix treatment started on day 5 or on day 6 of ovarian stimulation

 

Ganirelix started on day 5 (n = 961)

Ganirelix started on day 6 (n = 1135)

Age, y, mean ± SD

31.5 ± 3.3

31.4 ± 4.1

Body weight, kg, mean ± SD

66.2 ± 8.6

63.5 ± 10.2

BMI, kg/m 2 , mean ± SD

24.1 ± 3.0

23.4 ± 3.3

Region, %

  

North America

41.9

17.4

Asia

5.9

0

Middle East

0

24.4

Europe

52.1

58.2

Duration of infertility, y, mean ± SD

3.2 ± 2.2

4.6 ± 3.2

Primary infertility, %

54.0

57.8

Cause of infertility * , %

  

Male factor

47.7

51.9

Tubal factor

24.3

32.2

Endometriosis

14.0

8.7

Cervical mucus problems

0.6

1.2

Unexplained infertility

28.8

13.7

Other

6.0

4.1

  1. BMI body mass index, SD standard deviation.
  2. *A patient could have more than one cause of infertility.